tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Ashik Kurian, 6 are a BUY (50%), 6 are a HOLD (50%).
Analyst Ashik Kurian, currently employed at CITI, carries an average stock price target met ratio of 50% that have a potential upside of 16.12% achieved within 352 days. Previously, Ashik Kurian worked at JEFFERIES, STEPHENS.
Ashik Kurian’s has documented 27 price targets and ratings displayed on 4 stocks. The coverage is on the Consumer Cyclical sector.
Most recent stock forecast was given on MRSN, Mersana Therapeutics at 28-Jul-2023.
Analyst best performing recommendations are on VNE (VEONEER).
The best stock recommendation documented was for VNE (VEONEER) at 7/16/2018. The price target of $50 was fulfilled within 2 days with a profit of $1.52 (3.14%) receiving and performance score of 15.68.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Dec-2023
$122
$2.83 (2.37%)
$113
13 days ago
(25-Jun-2026)
34/37 (91.89%)
$1.19 (0.99%)
233
Hold Since 15-Jun-2026
$122
$2.83 (2.37%)
$124
23 days ago
(15-Jun-2026)
5/5 (100%)
$-3.79 (-3.01%)
144
Buy Since 07-Mar-2025
$150
$30.83 (25.87%)
$147
2 months 18 days ago
(20-Apr-2026)
30/34 (88.24%)
$28.64 (23.60%)
432
Hold Since 20-Oct-2020
$130
$10.83 (9.09%)
$133
2 months 18 days ago
(20-Apr-2026)
20/23 (86.96%)
$8.64 (7.12%)
272
Buy Since 25-Jun-2025
$138
$18.83 (15.80%)
$141
2 months 18 days ago
(20-Apr-2026)
0/4 (0%)
$16.64 (13.71%)
What Year was the first public recommendation made by Ashik Kurian?
